Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease
Status:
Completed
Trial end date:
2013-04-01
Target enrollment:
Participant gender:
Summary
A higher prevalence of Helicobacter pylori infection rate has been demonstrated among PD
patients compared to controls. As H. pylori infection is known to interfere with levodopa
absorption, we embarked on this is a study to understand the effects of Helicobacter pylori
infection eradication among a selected Malaysian population with Parkinsons disease, in
relation to levodopa effectiveness and motor improvements.
The study hypotheses are:
1. H. pylori eradication improves L-dopa 'onset' time and prolongs the L-dopa 'on-time'
duration.
2. PD patients with H. pylori infection show clinical improvement in motor disability and
quality of life after eradication therapy of H. pylori, assessed using UPDRS-III / PDQ39
questionnaires.